4.7 Editorial Material

T cells are ready for the fight against monkeypox

Related references

Note: Only part of the references are listed.
Article Immunology

An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Yanchun Peng et al.

Summary: Specific CD8(+) T cell responses targeting NP105-113-B*07:02 are associated with mild COVID-19 disease and high antiviral efficacy, providing potential targets for T cell vaccine design. These T cell responses show long-lasting preservation of antiviral functionality post-infection.

NATURE IMMUNOLOGY (2022)

Article Microbiology

Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans

Alba Grifoni et al.

Summary: This study predicts potential MPXV targets using information from the Immune Epitope Database, enabling the monitoring of cellular immunity following MPXV infection and vaccination.

CELL HOST & MICROBE (2022)

Review Biochemistry & Molecular Biology

Genes that Control Vaccinia Virus Immunogenicity

S. N. Shchelkunov et al.

ACTA NATURAE (2020)

Review Microbiology

Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens

Magdalini Moutaftsi et al.

FUTURE MICROBIOLOGY (2010)

Review Virology

T-Cell epitope discovery for variola and vaccinia viruses

Richard Kennedy et al.

REVIEWS IN MEDICAL VIROLOGY (2007)